Business Context and Reporting Period
Company: Stepan Company
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2010
Business Overview: Stepan produces specialty and intermediate chemicals sold to manufacturers for use in detergents, personal care products, construction materials, and food/pharmaceutical applications. The company operates three reportable segments: Surfactants (74% of sales), Polymers (23% of sales), and Specialty Products (3% of sales).
Key 2010 Developments:
- Acquired manufacturing assets in Singapore (Peter Cremer GmbH) for $10.4 million to produce methyl esters.
- Acquired 100% of Alfa Systems Sp. z o.o. in Poland for approximately $11.8 million to expand polymer capabilities.
- Increased ownership in Stepan Philippines Inc. (SPI) from 50% to 88.8%, resulting in consolidation.
Key Financial Metrics
| Metric (in thousands) | 2010 | 2009 |
|---|---|---|
| Net Sales | $1,431,122 | $1,276,382 |
| Gross Profit | $235,978 | $233,103 |
| Operating Income | $107,897 | $104,888 |
| Net Income (Attributable to Stepan) | $65,427 | $63,049 |
| Diluted EPS | $5.90 | $5.84 |
| Cash Flow from Operations | $66,126 | $166,441 |
| Total Debt | $191,572 | $104,084 |
| Cash and Cash Equivalents | $111,198 | $98,518 |
| Capital Expenditures | $73,748 | $42,631 |
Material Changes vs. Prior Period
Revenue Growth: Net sales increased 12% ($154.7 million) driven by higher average selling prices ($82.8 million) and increased sales volumes ($68.0 million). Foreign currency translation contributed $3.9 million.
Profitability: Operating income rose 3% ($3.0 million). While gross profit increased slightly, margins were pressured by rising raw material costs. A labor lockout at the Millsdale, Illinois site negatively impacted surfactant gross profit.
Segment Performance:
- Surfactants: Sales up 9%; Operating income down 6% due to lower margins in Europe and labor dispute costs in North America.
- Polymers: Sales up 27%; Operating income up 9% driven by volume growth and improved margins in North America.
- Specialty Products: Sales down 1%; Operating income up 15% due to lower raw material costs and better product mix.
Guidance, Outlook, and Risks
Outlook: Management anticipates continued global recovery in the insulation market benefiting the polymers segment. The company plans to invest in scaling the enhanced oil recovery business and completing capacity expansions in Brazil, Germany, and Singapore.
Capital Expenditures: Estimated at $95 million to $100 million for 2011.
Key Risks:
- Raw Material Volatility: Costs for petroleum and plant-based materials are significant; the company may not always be able to pass these costs to customers immediately.
- Foreign Operations: Approximately 40% of sales are outside the U.S., exposing the company to currency fluctuations and political/economic instability.
- Environmental Liabilities: The company faces potential costs related to CERCLA sites (e.g., Maywood, NJ). Accrued liability is $15.9 million, with a possible loss range of $10.0 million to $29.7 million.
- Debt Covenants: The company must maintain specific interest coverage and net worth ratios; failure could trigger debt acceleration.
Investor Verification Checklist
- Working Capital Trends: Verify the sustainability of the $94.7 million unfavorable swing in working capital cash flow compared to 2009.
- Raw Material Pass-Through: Monitor the ability to maintain gross margins as raw material costs remain elevated relative to 2009.
- Debt Servicing: Review the impact of the increased debt load ($191.6 million) on future interest coverage ratios and liquidity.
- Acquisition Integration: Assess the financial contribution of the new Singapore, Poland, and Philippines assets in upcoming quarters.
- Environmental Reserves: Track updates on the Maywood, NJ site remediation costs and potential changes to the $15.9 million liability.